Zurich Cantonal Bank’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
2024
Q2
$539K Hold
2024
Q1
$557K Hold
2023
Q4
$558K Buy
2023
Q3
$264K Buy
2023
Q2
$323K Hold
2023
Q1
$248K Hold
2022
Q4
$320K Buy
2022
Q3
$202K Hold
2022
Q2
$189K Hold
2022
Q1
$250K Buy
2021
Q4
$178K Buy
2021
Q3
$88K Buy